Carton of Evorel Conti, hormone replacement therapy (HRT) patches

Carton of Evorel Conti (empty), hormone replacement therapy (HRT) patches containing estradiol and norethisterone, marketed by Theramex, London and made in Germany, c.2022. The box originally contained 24 estradiol and norethisterone (HRT) patches, and was used to manage the symptoms of menopauseby by the donor.

This box of Evorel Conti, is a form of combined and continuous hormone replacement therapy (HRT). It delivers two hormones, an oestrogen (estradiol) and a progestogen (norethisterone) via patches that pass the hormones slowly through the skin. The patches were used by the donor to manage the symptoms of menopause, a process that marks the end of the menstrual cycle, during which hormone levels decline.

The medication was marketed in the UK by Theramex, a pharmaceutical company specialising in women's health products. It was made in Germany, c.2022. The carton originally contained 24 patches. The patches needed to be changed twice a week to give the body a steady supply of hormones. Hormone replacement therapy like this is designed to alleviate the impact of symptoms such as hot flushes during menopause and lessen the risk of osteoporosis. The patches were instructed to be stuck to a hairless area of skin below the waist, often on the thigh or bottom.